Professor of Molecular Medicine, Anglia Ruskin University, UK
EXPLORING ADVANCES IN TECHNOLOGY AND RESEARCH IN QPCR, DPCR/NGS, MICROFLUIDICS & GENE EDITING
These tracks are designed for academic experts working in areas such as molecular biology/diagnostics, liquid biopsies, gene expression, genomics, biomarkers, pathogen detection, and miRNA analysis. The latest developments, opportunities and applications of both dPCR and qPCR will be examined, through case studies across diverse areas such as oncology, infectious diseases, vaccines, clinical applications, microbiology, and other novel applications. Increasing numbers of real-time PCR users are purchasing digital PCR due to the reduction in its cost, absolute quantification, improved sensitivity & precision, and greater robustness. As a result, the qPCR and Digital PCR market are predicted to grow to $4.94 billion by 2021. This conference, therefore, provides a timely opportunity to learn first-hand about dPCR, whilst also keeping up to date with the latest developments and strategies in qPCR.
With similar and shared methods and applications across the four main themes of the meeting, 4Bio Europe will provide a multi-disciplinary forum in which to discover crossover in your research, attend the latest cutting-edge talks that appeal to you most, and also network with your peers and discover solutions to the whole spectrum of your research all in one location.
CNRS Research Director, Group Leader, Translational Research and Microfluidics, Paris Descartes University, France
Professor of radiation oncology, Dana Farber Cancer Institute and Harvard Medical School, USA
Strategy & Technology for PCR-Based Methods
Applications of PCR-based technologies for: